Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,008,433,708
+$113,469,759 QoQ
Shares Held
4,007,446
-2.6% QoQ
Ownership
0.227%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#49
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $65,843,394,868 across 16 Drug Manufacturers - General names. ABBV ranks #3 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,322,720 | $61,558,015,176 | |
| 2 | JNJ |
Johnson & Johnson
|
5,664,275 | $1,438,555,915 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
4,007,446 | $1,008,433,708 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,286,803 | $936,354,184 | |
| 5 | AMGN |
Amgen Inc
|
1,067,124 | $386,426,938 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,236,299 | $186,475,541 | |
| 7 | PFE |
Pfizer Inc
|
6,711,470 | $161,612,193 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
476,166 | $60,158,808 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,008,433,708 | 4,007,446 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $894,963,949 | 4,114,966 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $946,620,129 | 4,142,939 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $994,564,321 | 4,295,432 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $758,435,148 | 4,085,956 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $867,035,452 | 4,138,199 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $736,090,617 | 4,142,322 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $856,796,005 | 4,338,647 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $747,052,442 | 4,355,483 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $806,400,892 | 4,428,341 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $733,055,051 | 4,730,303 | Shares | Defined | 2024-03-22 | |
| 2023-09-30 | $711,922,480 | 4,776,080 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $648,472,328 | 4,813,125 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $782,327,564 | 4,908,876 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $798,148,153 | 4,938,730 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $665,679,851 | 4,959,987 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $769,820,905 | 5,026,253 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $827,038,367 | 5,101,711 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $701,323,658 | 5,179,643 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $538,221,028 | 4,989,534 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $579,583,034 | 5,145,446 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $558,119,538 | 5,157,268 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $560,972,892 | 5,235,398 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $461,527,910 | 5,269,185 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $516,171,920 | 5,257,404 | Shares | Defined | 2020-08-28 | |
| 2020-03-31 | $365,752,148 | 4,800,527 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||